BioLineRx Ltd. - BLRX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$198K
QoQ value delta ($000)
+$21K (+11.86%)
Implied price effect (QoQ)
-24.38%
Shares
Total shares
71,451
QoQ shares delta
+23,151 (+47.93%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BLRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 14 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 171 60,251 0.0%
RHUMBLINE ADVISERS 9 3,353 0.0%
CITIGROUP INC 5 2,038 0.0%
UBS Group AG 5 1,951 0.0%
WELLS FARGO & COMPANY/MN 4 1,750 0.0%
BNP PARIBAS FINANCIAL MARKETS 4 1,500 0.0%
BANK OF AMERICA CORP /DE/ 0 10 0.0%
DANSKE BANK A/S 0 2 0.0%
MORGAN STANLEY 0 100 0.0%
GROUP ONE TRADING LLC 0 100 0.0%
NewEdge Advisors, LLC 0 107 0.0%
OSAIC HOLDINGS, INC. 0 26 0.0%
Rockefeller Capital Management L.P. 0 12 0.0%
Banque Cantonale Vaudoise 0 1 0.0%
Nemes Rush Group LLC 0 250 0.0%